IQ-AI Limited.
43 announcements.
43 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
07:00 | 20-11-2024 | IQAI | IQ-AI Limited | Imaging Biometrics Expands Distribution |
11:27 | 19-11-2024 | IQAI | IQ-AI Limited | Board Changes |
07:00 | 05-11-2024 | IQAI | IQ-AI Limited | New Patent Application and Trading Update |
12:08 | 14-10-2024 | IQAI | IQ-AI Limited | Holding(s) in Company |
12:05 | 14-10-2024 | IQAI | IQ-AI Limited | PDMR dealing and TR1 announcement |
10:42 | 11-10-2024 | IQAI | IQ-AI Limited | Acquisition of Interest by Braveheart |
09:59 | 25-06-2024 | IQAI | IQ-AI Limited | IB Opens Expanded Access Program |
08:38 | 14-06-2024 | IQAI | IQ-AI Limited | Clinical Trial Updates |
15:08 | 29-05-2024 | IQAI | IQ-AI Limited | Result of AGM |
07:00 | 23-05-2024 | IQAI | IQ-AI Limited | Major East Coast Health System Chooses IB Nimble |
07:00 | 17-05-2024 | IQAI | IQ-AI Limited | IB Software Enhances Clinical Decision-Making |
08:15 | 10-05-2024 | IQAI | IQ-AI Limited | Rare Pediatric Disease Designation Granted to GaM |
12:47 | 02-05-2024 | IQAI | IQ-AI Limited | IB Announces Expanded Access Program for GaM |
15:26 | 29-04-2024 | IQAI | IQ-AI Limited | Publication of Annual Report |
07:00 | 05-03-2024 | IQAI | IQ-AI Limited | Grant of Options |
08:20 | 01-03-2024 | IQAI | IQ-AI Limited | Holding(s) in Company |
08:22 | 01-03-2024 | IQAI | IQ-AI Limited | Holding(s) in Company |
07:00 | 26-02-2024 | IQAI | IQ-AI Limited | Result of Broker Option and Total Voting Rights |
07:00 | 22-02-2024 | IQAI | IQ-AI Limited | Placing and Broker Option |
12:49 | 09-02-2024 | IQAI | IQ-AI Limited | FDA Application Update |
08:39 | 02-02-2024 | IQAI | IQ-AI Limited | IB awarded a $100,000 grant |
10:05 | 22-01-2024 | IQAI | IQ-AI Limited | Holding(s) in Company |
07:00 | 15-01-2024 | IQAI | IQ-AI Limited | Holding(s) in Company |
07:01 | 15-01-2024 | IQAI | IQ-AI Limited | Director Dealings and Conversion of CLNs |
07:00 | 10-01-2024 | IQAI | IQ-AI Limited | IB Launching an Expanded Access Program for GaM |
14:29 | 19-12-2023 | IQAI | IQ-AI Limited | Imaging Biometrics granted FDA “Fast-Track†|
10:58 | 05-12-2023 | IQAI | IQ-AI Limited | IQ-AI Announces Positive Interim Phase 1 Results |
13:42 | 20-11-2023 | IQAI | IQ-AI Limited | Holding(s) in Company |
11:38 | 09-11-2023 | IQAI | IQ-AI Limited | Director Dealing and Conversion of CLNs |
10:59 | 08-11-2023 | IQAI | IQ-AI Limited | Application for Pediatric Rare Disease Designation |
13:02 | 06-11-2023 | IQAI | IQ-AI Limited | Holding(s) in Company |
14:29 | 18-10-2023 | IQAI | IQ-AI Limited | Update Regarding Imaging Biometrics LLC |
08:55 | 13-10-2023 | IQAI | IQ-AI Limited | IB Letter to Shareholders |
07:00 | 09-10-2023 | IQAI | IQ-AI Limited | Orphan Drug Status to GaM and Total Voting Rights |
11:30 | 03-10-2023 | IQAI | IQ-AI Limited | Holding(s) in Company |
14:32 | 19-09-2023 | IQAI | IQ-AI Limited | IQ-AI shares cease trading on the OTCQB |
07:00 | 08-09-2023 | IQAI | IQ-AI Limited | Reduced Gadolinium Approach Validated' |
12:06 | 18-08-2023 | IQAI | IQ-AI Limited | Update on Collaboration Agreement with Mayo Clinic |
11:20 | 18-08-2023 | IQAI | IQ-AI Limited | IB & GE HealthCare Enter into Commercial Agreement |
07:00 | 17-08-2023 | IQAI | IQ-AI Limited | Half-year Report |
07:00 | 13-07-2023 | IQAI | IQ-AI Limited | Orphan Drug Designation for GaM in Pediatric GBM |
11:02 | 23-05-2023 | IQAI | IQ-AI Limited | Result of AGM |
07:00 | 23-05-2023 | IQAI | IQ-AI Limited | AGM Statement |